Skip to main content

Table 1 Crude and age-standardized incidence rate of primary CNS tumors according to sex, histological subtype and malignancy statusa

From: Increasing incidence of central nervous system (CNS) tumors (2000–2012): findings from a population based registry in Gironde (France)

  n % Crude IR/100,000 Standardized IR/100000
Europe US World
Men 1526   18 16 16 13
Malignancy status
 Malignant (/3) 860 56 9.9 9.1 9.2 7.3
 Non-malignant (/1, /0) 666 44 7.7 7.2 7.2 5.9
Histological subtype
 Neuroepithelial tumors 843 55.2 9.7 9.1 9.1 7.3
 Meningeal tumors 346 22.7 4.0 3.5 3.7 2.5
 Cranial and spinal nerve tumors 208 13.6 2.4 2.3 2.2 1.8
 Lymphomas 57 3.7 0.66 0.58 0.58 0.38
 Other tumors 72 4.7 0.83 0.77 0.82 0.72
Female 1989   21 17 17 14
Malignancy status
 Malignant (/3) 688 35 7.3 5.9 5.9 4.6
 Non-malignant (/1, /0) 1301 65 14 12 12 9.1
Histological subtype
 Neuroepithelial tumors 653 32.8 6.9 5.8 5.8 4.9
 Meningeal tumors 975 49.0 10.4 8.4 8.4 6.5
 Cranial and spinal nerve tumors 214 10.8 2.3 2.1 2.0 1.7
 Lymphomas 58 2.9 0.62 0.45 0.47 0.35
 Other tumors 89 4.5 0.94 0.72 0.77 0.68
All 3515   19 17 17 13
Malignancy status
 Malignant (/3) 1548 44 8.6 7.4 7.4 5.9
 Non-malignant (/1, /0) 1967 56 11 9.5 9.6 7.6
Histological subtype
 Neuroepithelial tumors 1496 42.5 8.3 7.4 7.3 6.1
 Meningeal tumors 1321 37.6 7.3 6.1 6.2 4.5
 Cranial and spinal nerve tumors 422 12.0 2.3 2.2 2.1 1.8
 Lymphomas 115 3.3 0.64 0.51 0.52 0.37
 Other tumors 161 4.6 0.89 0.75 0.80 0.70
  1. aPituitary tumors, tumors associated with AIDS, recurrence of tumors, and metastatic tumors were not included in the registry